SuCGJudgeTALichensteinGR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307-327.
2.
JacquesPMielantsHCoppietersKDe VosMElewautD. The intimate relationship between gut and joint in spondyloarthropathies. Curr Opin Rheumatol. 2007;19:353-357.
3.
JoseFAGarnettEAVittinghoffE. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:63-68.
4.
Dekker-SaeysBJMeuwissenSGVan Den Berg-LoonenEM. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis. 1978;37:33-35.
5.
de VlamKMielantsHCuvelierCDe KeyserFVeysEMDe VosM. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol. 2000;27:2860-2865.
6.
PalmOMoumBOngreAGranJT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002;29:511-515.
7.
TaccariESpadaroARiccieriVGuerrisiRGuerrisiVZoppiniA. Sternoclavicular joint disease in psoriatic arthritis. Ann Rheum Dis. 1992;51:372-374.
8.
WeberUPfirrmannCWKisslingROHodlerJZanettiM. Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis. BMC Musculoskelet Disord. 2007;8:20-32.
9.
RossJJShamsuddinH. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore). 2004;83:139-148.
10.
ChenWSWanYLLuiCCLeeTYWangKC. Extrapleural abscess secondary to infection of the sternoclavicular joint. Report of two cases. J Bone Joint Surg Am. 1993;75:1835-1839.
11.
EvansJMMcMahonADMurrayFEMcDevittDGMacDonaldTM. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut. 1997;40:619-622.
12.
McCartneySAMitchellJAFaircloughPDFarthingMJWarnerTD. Selective COX-2 inhibitors and human inflammatory bowel disease. Aliment Pharmacol Ther. 1999;13:1115-1117.
13.
TakeuchiKSmaleSPremchandP. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4:196-202.
